Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07003113 · ClinicalTrials.gov registry record · NA
Ischemic Preconditioning in Osteoarthritis and Back Pain
A NA study of Low Back Pain and Knee Osteoarthritis, sponsored by University of Illinois at Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT07003113: Recruiting NA study of Low Back Pain and Knee Osteoarthritis, sponsored by University of Illinois at Chicago.
NCT07003113 is a NA study of Low Back Pain and Knee Osteoarthritis that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 24 participants, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07003113, a NA study of Low Back Pain and Knee Osteoarthritis, is actively recruiting participants, sponsored by University of Illinois at Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
We are examining the use of restricted blood flow, through full occlusion, on a single thigh for 50 minutes (5 minutes on, 5 minutes off), completed every other day for 2 weeks to improve function in individuals with knee osteoarthritis and low back pain.
Primary Outcome
Changes in preferred walking speed (m/s) from intervention
Conditions Studied
Interventions
- DEVICE Ischemic Preconditioning
- DEVICE Sham Intervention
Study Locations (1)
Illinois
- Human and Sport Performance Lab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-09-12 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT07003113 shows while recruiting
NCT07003113 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 504-participant average among 122 other Low Back Pain trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Ischemic Preconditioning is the first listed.
NCT07003113 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07003113 about?
NCT07003113 is a clinical study titled "Ischemic Preconditioning in Osteoarthritis and Back Pain". We are examining the use of restricted blood flow, through full occlusion, on a single thigh for 50 minutes (5 minutes on, 5 minutes off), completed every other day for 2 weeks to improve function in individuals with knee osteoarthritis and low back pain.
What is the current status of trial NCT07003113?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-09-12. Estimated completion is 2026-12-31.
What conditions does trial NCT07003113 study?
This clinical trial studies the following conditions: Low Back Pain, Knee Osteoarthritis.
What interventions are being tested in trial NCT07003113?
The interventions under investigation include: Ischemic Preconditioning (DEVICE), Sham Intervention (DEVICE).
Who is sponsoring clinical trial NCT07003113?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07003113 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07003113's enrollment target sits among peer trials
24 114th of 122 higher than 8 of 122 other Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Erector Spinae Plane Block for Acute Back Pain in the Emergency Department
RECRUITING · NA
-
A Multi-Site Feasibility Trial of Embedded Emergency Department Physical Therapy
RECRUITING · NA
-
Feasibility of Identifying Brain Mechanisms of Qigong and Behavioral Outcomes After Qigong Practice in People With Chronic Low Back Pain
RECRUITING · NA
-
Neural Mechanisms of Meditation for Opioid-Treated Chronic Low Back Pain
RECRUITING · NA
-
Perspectives on Spinal Manipulative Therapy for Low Back Pain
RECRUITING · NA
-
Effect of Lumbar Manipulation on Intervertebral Motion, Pain, and Disability
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI